Treat Ovarian Cancer With Genetics.

We’ve helped thousands of patients decide on their ovarian cancer treatment plan

Myriad Genetics

When It Comes To Ovarian Cancer Trust the Innovators of the BRCA gene 

Genetics testing provides critical information for making treatment decisions for ovarian cancer. 1 in 4 women with ovarian cancer will test positive to having a genetic mutation.  Testing results will also inform you if you are at an elevated risk for additional cancers such as breast cancer, or if your family has an elevated risk for cancer and what preventative actions they can take.

 

What does Myriad provide?

Myriad Genetics is known for its industry leading accuracy. Armed with this information, you and your doctor no longer have to do trial and error. You can start creating a treatment plan that is personalized to you.  

What is Hereditary Breast and Ovarian Cancer?

What Answers Do Each Test Provide?

HEREDITARY CANCER TESTING

MyRisk

For cancer patients:
Myriad myRisk® is a gene panel that helps identify your options for treatment and your risk of additional cancers.
 
For health individuals:
Myriad myRisk® will identity if you are at an elevated risk of developing cancer.
 
Cancer screening test
myChoiceCDx ovarian cancer test for parp inhibitors

OVARIAN CANCER TREATMENT TESTING -TO HELP DETERMINE WHICH PATIENTS MAY BE APPROPRIATE FOR PARP INHIBITOR THERAPY

MyChoice CDx

MyChoice CDx allows you to decide you are eligible for PARP Inhibitor therapy. Each test gives you a clear yes or no answer. 

 

Hereditary Cancer Testing for Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2)

BRACAnalysis

BRACAnalysis ® is a genetic test that detects the presence of a BRCA1 or BRCA2 gene mutation. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87 percent for developing breast cancer and 39-63 percent for developing ovarian cancer by age 70.

BRCa1 BRCA1 Blood test for breast cancer
NGS test for genetic testing for cancer. Tumor marker test for cancer treatment in India. PositiveSelect Plus

OVARIAN CANCER TREATMENT OPTIONS

PositiveSelect Plus

PositiveSelect Plus provides patients with treatment options such as chemotherapy, targeted therapy and immunotherapy options. 

Tumor Normal Match For Ovarian Cancer Treatment Options

PositiveSelect Ultimate

PositiveSelect Ultimate is a genetic test that tests both cancer cells as well as normal blood cells. In addition to the PositiveSelect Plus test benefits, PositiveSelect Ultimate identifies somatic and germ line mutations.

ultimate cancer test for best cancer treatment in india

Why Hereditary Testing for Ovarian Cancer?

Knowing whether your cancer was caused by a genetic mutation will help guide treatment decisions, determine your risk of developing additional cancers (like breast cancer), and identify your close family members’ risks of having the same mutation (50% chance).

Individuals with an identified hereditary cancer risk have up to a 63% lifetime risk of developing ovarian cancer. They are also at a much higher risk of developing other cancers, such as breast and pancreatic cancer, than the general public.

Did you know? Up to 1 in 4 incidences of ovarian cancer are due to hereditary causes.